The TMC Innovation, together with the Biomedical Advanced Research and Development Authority (BARDA), Division of Research, Innovation and Ventures (DRIVe) is working with a network of accelerators across America to promote national health security innovation.

The goal is to populate the R&D pipeline with candidate health security products and technologies that are ready to advance to later-stage funding outside of the accelerator network for clinical development and commercialization, to revolutionize our capability and capacity for national health security preparedness and response.

Learn more about the program by visiting the Department of Health and Human Services website.

The TMC ACT program is funded by the Cancer Research Institute of Texas and is supported by collaboration with the Gulf Coast Consortia and UTMB.